Imfinzi plus BCG induction and maintenance therapy showed a statistically and clinically meaningful improvement in DFS for ...

Dr. Kara Kelly discusses some of the most common challenges faced by adolescent and young adult patients with lymphoma.

I’m 22 years out from breast cancer and forever grateful for the nurses who gave me not just treatment but friendship, ...

Treatment with the Avmapki Fakzynja Co-pack received accelerated FDA approval for previously treated low-grade serous ovarian ...

The first trial site has been initiated in the pivotal phase 3 OVATION 3 study which will investigate IMNN-001 for newly ...

Dr. Daniel J. Boffa shared how cancer care teams support patients in quitting smoking and how new data may guide improvements ...

Biomarker testing is vital for all patients with lung cancer, especially younger individuals who have higher rates of ...

Danyelza is now a recommended treatment in NCCN guidelines for relapsed or refractory high-risk neuroblastoma, a type of ...

Dr. Kara Kelly discusses the unique challenges that adolescent and young adult patients with cancer face following their ...

Treatment with an Enhertu regimen significantly improved pathologic complete responses for patients with high-risk ...

Dr. Shirley D'Sa discusses the importance of catching peripheral neuropathy in patients with Waldenstrom macroglobulinemia ...

The first patient was dosed in the SKYBRIDGE study assessing peluntamig with Tecentriq for advanced small cell lung cancer ...